| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 St. Michael's Hospital, Dept of Medicine and 2 Dept of Psychiatry, University of Toronto, Toronto, ON, Canada
CORRESPONDENCE: P.J. Hanly, St. Michael's Hospital, 30 Bond Street, Suite 6-049, Toronto, ON, Canada, MSB 1W8. Fax: 41 68645922. E-mail: hanlyp@smh.toronto.on.ca
Keywords: daytime sleepiness, hypoxaemia, neurocognitive function, sleep
Received: October 12, 2000
Accepted October 25, 2001
This study was supported by the Canadian Cystic Fibrosis Foundation
It was hypothesized that adult cystic fibrosis (CF) patients with severe lung disease have impaired daytime function related to nocturnal hypoxaemia and sleep disruption.
Nineteen CF patients (forced expiratory volume in one second 28±7% predicted) and 10 healthy subjects completed sleep diaries, overnight polysomnography (PSG), and assessment of daytime sleepiness and neurocognitive function.
CF patients tended to report more awakenings (0.7±0.5 versus 0.3±0.2·h–1, p=0.08), and PSG revealed reduced sleep efficiency (71±25 versus 93±4%, p=0.004) and a higher frequency of awakenings (4.2±2.7 versus 2.4±1.4·h–1, p=0.06). Mean arterial oxygen saturation during sleep was lower in CF patients (84.4±6.8 versus 94.3±1.5%, p<0.0001) and was associated with reduced sleep efficiency (regression coefficient (r)=0.57, p=0.014). CF patients had short sleep latency on the multiple sleep latency test (6.7±3 min). The CF group reported lower levels of activation and happiness and greater levels of fatigue (p<0.01), which correlated with indices of sleep loss, such as sleep efficiency (r=0.47, p=0.05). Objective neurocognitive performance was also impaired in CF patients, reflected by lower throughput for simple addition/subtraction, serial reaction and colour-word conflict.
The authors concluded that adult cystic fibrosis patients with severe lung disease have impaired neurocognitive function and daytime sleepiness, which is partly related to chronic sleep loss and nocturnal hypoxaemia.
This article has been cited by other articles:
|
|
 |
|
  K. R. Casey, K. O. Cantillo, and L. K. Brown Sleep-Related Hypoventilation/Hypoxemic Syndromes Chest, June 1, 2007; 131(6): 1936 - 1948. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Amin, J. Bean, K. Burklow, and J. Jeffries The Relationship Between Sleep Disturbance and Pulmonary Function in Stable Pediatric Cystic Fibrosis Patients Chest, September 1, 2005; 128(3): 1357 - 1363. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Dobbin, D. Bartlett, K. Melehan, R. R. Grunstein, and P. T. P. Bye The Effect of Infective Exacerbations on Sleep and Neurobehavioral Function in Cystic Fibrosis Am. J. Respir. Crit. Care Med., July 1, 2005; 172(1): 99 - 104. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Jankelowitz, K. J. Reid, L. Wolfe, J. Cullina, P. C. Zee, and M. Jain Cystic Fibrosis Patients Have Poor Sleep Quality Despite Normal Sleep Latency and Efficiency Chest, May 1, 2005; 127(5): 1593 - 1599. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
